Every material Form 8-K Concentrix filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Concentrix reported fiscal third-quarter 2025 results for the period ended August 31, 2025, with revenue up 4.0% to $2.48 billion and GAAP net income rising to $88.1 million from $16.6 million. Non-GAAP operating income and non-GAAP diluted EPS both declined year-on-year, while the company raised its full-year constant currency revenue growth outlook and increased its quarterly dividend. For shareholders, the top line and GAAP profit improved, but the company's adjusted profit measures fell.
Revenue of $2.48 billion, up 4.0% year-on-year (2.6% on a constant currency basis), exceeding the company's guidance for the quarter.
Non-GAAP diluted EPS of $2.78 vs. $2.87 a year earlier, down 3.1%; GAAP diluted EPS of $1.34 vs. $0.25.
Full-year fiscal 2025 constant currency revenue growth outlook raised to 1.75% to 2.0%; fourth-quarter reported revenue expected at $2.525 billion to $2.550 billion.
Quarterly dividend increased to $0.36 per share from $0.33275, payable November 4, 2025.
Concentrix reported fiscal second-quarter 2025 revenue of $2,417.4 million, up 1.5% from a year earlier, and raised its full-year constant currency revenue growth outlook to 1.0% to 2.0%. GAAP diluted EPS fell 35.7% to $0.63, while non-GAAP diluted EPS was $2.70 versus $2.69, and management cited mid-quarter program pauses and investments as reasons non-GAAP operating income declined 5.4%.
Q2 revenue of $2,417.4 million, up 1.5% year-on-year; GAAP operating income of $148.3 million, down 1.3%
GAAP diluted EPS of $0.63 versus $0.98; non-GAAP diluted EPS of $2.70 versus $2.69
Full-year 2025 reported revenue guidance of $9.720 billion to $9.815 billion; non-GAAP EPS guidance of $11.53 to $11.76
Adjusted free cash flow of $200.3 million in the quarter; company expects $625 million to $650 million for fiscal 2025 and about $240 million returned to shareholders
Concentrix director Olivier Duha notified the board on June 3, 2025 that he is resigning, effective immediately, including from all board committees. The company said the resignation was for personal reasons and not due to any disagreement over operations, policies or practices.
Resignation notified to the board on June 3, 2025; effective immediately
Duha also leaves all board committees
Company states the resignation was for personal reasons, not a disagreement with the company
Concentrix entered into an Amendment and Restatement Agreement on April 11, 2025, with Bank of America, N.A. taking over as administrative agent from JPMorgan Chase Bank, N.A. The restated credit agreement provides a $1.1 billion revolving facility, a $750 million unsecured term loan, and up to $750 million of delayed draw term loans, and the company also amended its receivables securitization facility. For shareholders, the filing sets new debt terms and maturities, and the company intends to use the delayed draw loans to repay a €700 million promissory note issued for the Webhelp combination.
Revolving credit facility of up to $1.1 billion, maturing April 11, 2030
New $750 million three-year term loan, with $250 million three-year and $500 million five-year delayed draw term loans that must be funded by September 30, 2025
Delayed draw loan proceeds intended to repay in full a €700 million promissory note issued to sellers in the September 2023 Webhelp combination
Financial covenants require a consolidated leverage ratio of no more than 3.75 to 1.00 and an interest coverage ratio of at least 3.00 to 1.00
Concentrix reported first-quarter fiscal 2025 results for the period ended February 28, 2025. Revenue fell 1.3% from a year earlier to $2.37 billion, while GAAP diluted earnings per share rose 36.8% to $1.04 and non-GAAP diluted EPS rose 8.6% to $2.79. The company reiterated its full-year fiscal 2025 guidance and gave second-quarter outlook figures.
Q1 revenue of $2,372.2 million, down 1.3% year-on-year as reported and up 1.3% in constant currency
GAAP diluted EPS of $1.04 versus $0.76; non-GAAP diluted EPS of $2.79 versus $2.57
Adjusted free cash flow was a use of $39.8 million in the quarter; full-year adjusted free cash flow expected at $625 million to $650 million
Second-quarter non-GAAP EPS expected at $2.69 to $2.80; full-year fiscal 2025 reported revenue expected at $9.490 billion to $9.635 billion
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Concentrix filing is on SEC EDGAR ↗. 8-K briefs of other companies →